View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/CMS RIN: 0938-AU66 Publication ID: Fall 2021 
Title: Prescription Drug and Health Care Spending (CMS-9905) 
Abstract:

This interim final rule implements the prescription drug reporting requirements that apply to group health plans and health insurance issuers offering coverage in the group and individual markets under section 204 of title II of Division BB of the Consolidated Appropriations Act of 2021.

 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: Yes  Unfunded Mandates: No 
CFR Citation: 45 CFR 149   
Legal Authority: Pub. L. 116-260, Division BB, title II   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Request for Information  06/23/2021  86 FR 32813   
RFI Comment Period End  07/23/2021 
Interim Final Rule  11/23/2021  86 FR 66662   
Interim Final Rule Effective  12/23/2021 
Interim Final Rule Comment Period End  01/24/2022 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: Local, State 
Small Entities Affected: No  Federalism: Yes 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Related Agencies: Joint: DOL/EBSA, TREAS/IRS, OPM; 
Agency Contact:
Christina Whitefield
Director, Medical Loss Ratio Division
Department of Health and Human Services
Centers for Medicare & Medicaid Services
Center for Consumer Information and Insurance Oversight, MS: 733H.02, 7500 Security Blvd,
Baltimore, MD 21244
Phone:301 492-4172
Email: christina.whitefield@cms.hhs.gov